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EDITORIAL
Exciting Developments for 2005
Freek J. Zijlstra
Department of Anesthesiology, Erasmus MC, Centre location, PO Box 2040,
3000 CA Rotterdam, The Netherlands; f.zijlstra@erasmusmc.nl
It is again a pleasure to welcome readers of the journal
at the start of a new volume of the rapid journal Media-
tors of Inﬂammation. While in 2005 this journal will look
much the same as it has been in the past, starting with
this issue one main change has been made: the journal
has changed publishers from Taylor & Francis to Hindawi
Publishing Corporation. This change of the publisher has
notinterferedwiththepublicationofresearchpaperscur-
rently under submission.
The Editors herewith would like to thank the staﬀ at
Taylor & Francis for their help in the further development
of this publication into an excellent journal in the ﬁeld of
immunology and inﬂammation.
Last year, we observed a growing interest in the ﬁeld
of immunopharmacology of inﬂammation, resulting in
a continuous ﬂow of research papers. Manuscripts were
submitted from all over the world, from Brazil to Japan,
from Scandinavia to South Africa. The impact factor of
the journal currently ﬂuctuates around 1.00, which shows
a signiﬁcant rise in impact since 2002 when the ﬁgure
was 0.69. Hopefully an increase in high-quality submis-
sions will help improve the journal’s impact even further
in 2005.
Authors are encouraged to submit their papers by
electronic mail in order to improve the reviewing pro-
cess as well as the speed of acceptance and publication.
Following acceptance, the manuscript will be available
on the website of the journal, http://mi.hindawi.com,a s
soon as possible. Both the Editors and Hindawi Publish-
ing Corporation will do everything possible for a publi-
cation speed of approximately 4 months from submission
to publication, which is extremely good for a bimonthly
journal.
Meanwhile, the Editorial Board has been streamlined
and the main Editorial positions consolidated.
We look forward to receiving innovative papers for
Mediators of Inﬂammation on all aspects of the immunol-
ogy, molecular biology, and pharmacology of inﬂamma-
tion. In particular, papers describing clinical research and
how to manipulate through speciﬁc pharmacological in-
tervention are strongly welcomed. We are proud to pub-
lish all these peer-reviewed manuscripts in glossy print,
but papers will of course also be available in electronic
form on the Internet.
As a ﬁnal note, I would like to announce the intro-
duction of a new feature beginning with Volume 2005 of
Mediators of Inﬂammation, a hybrid open access option.
What this option will do is allow authors to make their ar-
ticles freely available online, without any subscription or
registration barriers, by paying a one-time “Open Access
Charge.” I would encourage all of our authors to consider
this new innovative feature. Now I would like to welcome
you all to Volume 2005 of Mediators of Inﬂammation.
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